Glutamate signaling in the pathophysiology and therapy of prenatal insults

Pharmacology Biochemistry and Behavior

Volumn 100, Issue 4, 2012, Pages 825-834

  Holopainen, Irma E ^a   Laurén, Hanna B ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

AMPA receptor; Hypoxia ischemia; Immature brain; Ionotropic glutamate receptor; KA receptor; Metabotropic glutamate receptor; NMDA receptor; Oligodendrocyte; Periventricular leukomalacia; Preterm infant

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CYTOKINE; DIZOCILPINE; ENDOCANNABINOID; ERYTHROPOIETIN; GABAPENTIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IBOTENIC ACID; IFENPRODIL; INTERLEUKIN 1BETA; INTERLEUKIN 6; ION CHANNEL; LAMOTRIGINE; MAGNESIUM SULFATE; MEMANTINE; METABOTROPIC RECEPTOR; MINOCYCLINE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2D; PHENOBARBITAL; PHENYTOIN; TETRACYCLINE; TOPIRAMATE; VALPROIC ACID;

ALZHEIMER DISEASE; APOPTOSIS; ASTROCYTE; BRAIN DAMAGE; BRAIN INJURY; BRAIN ISCHEMIA; CELL CULTURE; CELL PROLIFERATION; DENDRITIC SPINE; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; EXCITOTOXICITY; GENE EXPRESSION; GLIA CELL; HIPPOCAMPUS; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VITRO STUDY; INFLAMMATION; ION CONDUCTANCE; MEMORY CONSOLIDATION; MICROGLIA; MYELINATION; NERVE CELL LESION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEWBORN DISEASE; NONHUMAN; OLIGODENDROGLIA; PERINATAL ASPHYXIA; PERIVENTRICULAR LEUKOMALACIA; PERIVENTRICULAR LEUKOMALASIA; POSTNATAL DEVELOPMENT; PREECLAMPSIA; PREMATURITY; PRENATAL DISORDER; PRIORITY JOURNAL; REVIEW; SEIZURE;

ANIMALIA;

EID: 84855563269     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.03.016     Document Type: Article

References (142)

1. Alberdi E, Sanchez-Gomez MV, Marino A, Matute C. Ca(2+) influx through AMPA or kainate receptors alone is sufficient to initiate excitotoxicity in cultured oligodendrocytes. Neurobiol Dis 2002;9:234-43. (Pubitemid 34261217)
2. Al-Hallaq RA, Jarabek BR, Fu Z, Vicini S, Wolfe BB, Yasuda RP. Association of NR3A with the N-methyl-D-aspartate receptor NR1 and NR2 subunits. Mol Pharmacol 2002;62:1119-27. (Pubitemid 35222503)
3. Alix JJ, Fern R. Glutamate receptor-mediated ischemic injury of premyelinated central axons. Ann Neurol 2009;66:682-93.
4. Alvarez-Diaz A, Hilario E, de Cerio FG, Valls-i-Soler A, Alvarez-Diaz FJ. Hypoxic-ischemic injury in the immature brain-key vascular and cellular players. Neonatology 2007;92:227-35. (Pubitemid 350125279)
5. Aracava Y, Pereira EFR, Maelicke A, Albuquerque EX. Memantine blocks α7*nicotinic acetylcholine receptors more potently than N-methyl-D-aspartate receptors in rat hippocampal neurons. J Pharmacol Exp Ther 2005;312:1195-205. (Pubitemid 40293781)
6. Avallone J, Gashi E, Magrys B, Friedman LK. Distinct regulation of metabotropic glutamate receptor (mGluR1 alpha) in the developing limbic system following multiple early-life seizures. Exp Neurol 2006;202:100-11. (Pubitemid 44344252)
7. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 1998;18:6241-53. (Pubitemid 28373231)
8. Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001;21:1302-12. (Pubitemid 32128775)
9. Back SA, Han BH, Luo NL, Chricton CA, Xanthoudakis S, Tam J, et al. Selective vulnerability of late oligodendrocyte progenitors to hypoxia-ischemia. J Neurosci 2002;22:455-63. (Pubitemid 34049083)
10. Bakiri Y, Hamilton NB, Karadottir R, Attwell D. Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter. Glia 2008;56:233-40. (Pubitemid 350292315)
11. Barger SW, Goodwin ME, Porter MM, Beggs ML. Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J Neurochem 2007;101:1205-13. (Pubitemid 46718822)
12. Beattie MS, Ferguson AR, Bresnahan JC. AMPA-receptor trafficking and injury-induced cell death. Eur J Neurosci 2010;32:290-7.
13. A, NMDA and AMPA receptors: a developmentally regulated 'menage a trois'. Trends Neurosci 1997;20:523-9.
14. Bernaudin M, Bellail A, Marti HH, Yvon A, Vivien D, Duchatelle I. Neurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brain. Glia 2000;30:271-8. (Pubitemid 30259666)
15. Bittigau P, Sifringer M, Pohl D, Stadthaus D, Ishimaru M, Shimizu H, et al. Apoptotic neurodegeneration following trauma is markedly enhanced in the immature brain. Ann Neurol 1999;45:724-35. (Pubitemid 29260749)
16. Bittigau P, Sifringer M, Genz K, Reith E, Pospischil D, Govindarajalu S, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002;99:15089-94. (Pubitemid 35334614)
17. Calabresi P, Centonze D, Cupini LM, Costa C, Pisani F, Bernardi G. Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies. Neurobiol Dis 2003;12:82-8. (Pubitemid 36259970)
18. Cammer W, Zhang H. Maturation of oligodendrocytes is more sensitive to TNF-α than is survival of precursors and immature oligodendrocytes. J Neuroimmunol 1999;97:37-42. (Pubitemid 29301411)
19. Catania MV, Landwehrmeyer GB, Testa CM, Standaert DG, Penney Jr JB, Young AB. Metabotropic glutamate receptors are differentially regulated during development. Neuroscience 1994;61:481-95. (Pubitemid 24240298)
20. Chen J, Cai F, Cao J, Zhang X, Li S. Long-term antiepileptic drug administration during early life inhibits hippocampal neurogenesis in the developing brain. J Neurosci Res 2009;87:2898-907.
21. Conn PJ, Pin JP. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997;37:205-37. (Pubitemid 27238875)
22. Cull-Candy SG, Leszkiewicz DN. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004:re16.
23. Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 2001;11:327-35. (Pubitemid 32524098)
24. Das S, Sasaki YF, Rothe T, Premkumar LS, Takasu M, Crandall JE, et al. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 1998;393:377-81. (Pubitemid 28269712)
25. Davies A, Hendrich J, Van Minh AT, Wratten J, Douglas L, Dolphin AC. Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels. Trends Pharmacol Sci 2007;28:220-8. (Pubitemid 46661004)
26. Defagot MC, Villar MJ, Antonelli MC. Differential localization of metabotropic glutamate receptors during postnatal development. Dev Neurosci 2002;24:272-82. (Pubitemid 35404264)
27. Deng W. Neurobiology of injury to the developing brain. Nat Rev Neurol 2010;6:328-36.
28. Deng W, Rosenberg PA, Volpe JJ, Jensen FE. Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc Natl Acad Sci USA 2003;100:6801-6. (Pubitemid 36666660)
29. Deng W, Wang H, Rosenberg PA, Volpe JJ, Jensen FE. Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc Natl Acad Sci USA 2004;101:7751-6. (Pubitemid 38658101)
30. Di Giorgi Gerevini VD, Caruso A, Cappuccio I, Ricci Vitiani L, Romeo S, Della Rocca C, et al. The mGlu5 metabotropic glutamate receptor is expressed in zones of active neurogenesis of the embryonic and postnatal brain. Brain Res Dev Brain Res 2004;150:17-22. (Pubitemid 39090079)
31. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev 1999;51:7-61. (Pubitemid 29113865)
32. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979;3:79-83. (Pubitemid 9141710)
33. Domercq M, Sanchez-Gomez MV, Sherwin C, Etxebarria E, Fern R, Matute C. System xcand glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J Immunol 2007;178:6549-56. (Pubitemid 46717438)
34. Dong H, Csernansky CA, Goico B, Csernansky JG. Hippocampal neurogenesis follows kainic acid-induced apoptosis in neonatal rats. J Neurosci 2003;23:1742-9. (Pubitemid 36314729)
35. Dube L, Granry JC. The therapeutic use of magnesium in anesthesiology, intensive care and emergency medicine: a review. Can J Anaesth 2003;50:732-46. (Pubitemid 37321981)
36. Dunah AW, Yasuda RP, Wang YH, Luo J, Dávila-García M, Gbadegesin M, et al. Regional and ontogenic expression of the NMDA receptor subunit NR2D protein in rat brain using a subunit-specific antibody. J Neurochem 1996;67:2335-45. (Pubitemid 26392503)
37. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 2009;16:966-75.
38. Fabene PF, Navarro Mora G, Martinello M, Rossi B, Merigo F, Ottoboni L, et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 2008;14:1377-83.
39. Faiella A, Wernig M, Consalez GG, Hostick U, Hofmann C, Hustert E, et al. A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression. Hum Mol Genet 2000;9:227-36. (Pubitemid 30052746)
40. Fathali N, Ostrowski RP, Lekic T, Jadhav V, Tong W, Tang J, et al. Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury. Crit Care Med 2010;38:572-8.
41. Fogal B, Hewett SJ. Interleukin-1beta: a bridge between inflammation and excitotoxicity? J Neurochem 2008;106:1-23.
42. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 2000;20:9235-41. (Pubitemid 32042926)
43. Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 2004;24:4412-20. (Pubitemid 38608152)
44. Fontaine RH, Olivier P, Massonneau V, Leroux P, Degos V, Lebon S, et al. Vulnerability of white matter towards antenatal hypoxia is linked to a species-dependent regulation of glutamate receptor subunits. Proc Natl Acad Sci USA 2008;105:16779-84.
45. Fukaya M, Hayashi Y, Watanabe M. NR2 to NR3B subunit switchover of NMDA receptors in early postnatal motoneurons. Eur J Neurosci 2005;21:1432-6. (Pubitemid 40516642)
46. Gibson CS, MacLennan AH, Dekker GA, Goldwater PN, Dambrosia JM, Munroe DJ, et al. Genetic polymorphisms and spontaneous preterm birth. Obstet Gynecol 2007;109:384-91. (Pubitemid 46197432)
47. Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001;20:6969-78. (Pubitemid 34062289)
48. Guttmann RP, Sokol S, Baker DL, Simpkins KL, Dong Y, Lynch DR. Proteolysis of the Nmethyl-d-aspartate receptor by calpain in situ. J Pharmacol Exp Ther 2002;302:1023-30. (Pubitemid 34920222)
49. Hagberg H, Gilland E, Bona E, Hanson LA, Hahin-Zoric M, Blennow M, et al. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats. Pediatr Res 1996;40:603-9. (Pubitemid 26332589)
50. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007;10:1387-94. (Pubitemid 350014685)
51. Hanse E, Taira T, Lauri S, Groc L. Glutamate synapse in developing brain: an integrative perspective beyond the silent state. Trends Neurosci 2009;32:532-7.
52. Haut SR, Veliskova J, Moshe SL. Susceptibility of immature and adult brains to seizure effects. Lancet Neurol 2004;3:608-17. (Pubitemid 39221927)
53. Haydar TF, Wang F, Schwartz ML, Rakic P. Differential modulation of proliferation in the neocortical ventricular and subventricular zones. J Neurosci 2000;20:5764-74. (Pubitemid 30636905)
54. Hedtjärn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002;22:5910-9. (Pubitemid 35387635)
55. Hedtjärn M, Mallard C, Arvidsson P, Hagberg H. White matter injury in the immature brain: role of interleukin-18. Neurosci Lett 2005;373:16-20. (Pubitemid 39536213)
56. Henson MA, Roberts AC, Salimi K, Vadlamudi S, Hamer RM, Gilmore JH, et al. Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex. Cereb Cortex 2008;18:2560-73.
57. Henson MA, Roberts AC, Perez-Otano I, Philpot BD. Influence of the NR3A subunit on NMDA receptor functions. Prog Neurobiol 2010;91:23-37.
58. Hoffman DJ, Marro PJ, McGowan JE, Mishra OP, Delivoria-Papadopoulos M. Protective effect of MgSO4 infusion on nmda receptor binding characteristics during cerebral cortical hypoxia in the newborn piglet. Brain Res 1994;644:144-9.
59. Holopainen IE. Seizures in the developing brain: cellular and molecular mechanisms of neuronal damage, neurogenesis and cellular reorganization. Neurochem Int 2008;52:935-47.
60. Husson I, Rangon CM, Lelievre V, Bemelmans AP, Sachs P, Mallet J, et al. BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cereb Cortex 2005;15:250-61. (Pubitemid 40270194)
61. Ikonomidou C, Turski L. Antiepileptic drugs and brain development. Epilepsy Res 2010;88:11-22.
62. Ikonomidou C, Qin Y, Labruyere J, Kirby C, Olney JW. Prevention of trauma-induced neurodegeneration in infant rat brain. Pediatr Res 1996;39:1020-7. (Pubitemid 26000145)
63. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999;283:70-4. (Pubitemid 29044848)
64. Ikonomidou C, Bittigau P, Koch C, Genz K, Hoerster F, Felderhoff-Mueser U, et al. Neurotransmitters and apoptosis in the developing brain. Biochem Pharmacol 2001;62:401-5. (Pubitemid 32607721)
65. Ikonomidou C, Scheer I, Wilhelm T, Juengling FD, Titze K, Stöver B, et al. Brain morphology alterations in the basal ganglia and the hypothalamus following prenatal exposure to antiepileptic drugs. Eur J Paediatr Neurol 2007;11:297-301. (Pubitemid 47194447)
66. Itoh T, Beesley J, Itoh A, Cohen AS, Kavanaugh B, Coulter DA, et al. AMPA glutamate receptor-mediated calcium signaling is transiently enhanced during development of oligodendrocytes. J Neurochem 2002;81:390-402. (Pubitemid 34809364)
67. Jensen FE. The role of glutamate receptor maturation in perinatal seizures and brain injury. Int J Dev Neurosci 2002;20:339-47.
68. Jensen FE. Role of glutamate receptors in periventricular leukomalacia. J Child Neurol 2005;20:950-9.
69. Joo JY, Kim BW, Lee JS, Park JY, Kim S, Yun YJ, et al. Activation of NMDA receptors increases proliferation and differentiation of hippocampal neural progenitor cells. J Cell Sci 2007;120:1358-70. (Pubitemid 46780029)
70. Kadhim H, Tabarki B, Verellen G, De Prez C, Rona AM, Sébire G. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001;56:1278-84. (Pubitemid 32455283)
71. Kaindl AM, Asimiadou S, Manthey D, Hagen MV, Turski L, Ikonomidou C. Antiepileptic drugs and the developing brain. Cell Mol Life Sci 2006;63:399-413.
72. Karadottir R, Cavelier P, Bergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005;438:1162-6. (Pubitemid 41831686)
73. Kato H, Waltz W. The initiation of the microglial response. Brain Pathol 2000;10:137-43. (Pubitemid 30056401)
74. Kaur C, Ling EA. Periventricular white matter damage in the hypoxic neonatal brain: role of microglial cells. Prog Neurobiol 2009;87:264-80.
75. Kaur C, Sivakumar V, Ang LS, Sundaresan A. Hypoxic damage to the periventricular white matter in neonatal brain: role of vascular endothelial growth factor, nitric oxide and excitotoxicity. J Neurochem 2006;98:1200-16. (Pubitemid 44127795)
76. Keller M, Yang J, Griesmaier E, Gorna A, Sarkozy G, Urbanek M, et al. Erythropoietin is neuroprotective against NMDA-receptor-mediated excitotoxic brain injury in newborn mice. Neurobiol Dis 2006;24:357-66. (Pubitemid 44592570)
77. Kim J, Kondratyev A, Gale K. Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy. J Pharmacol Exp Ther 2007a;323:165-73. (Pubitemid 47443273)
78. Kim JS, Kondratyev A, Tomita Y, Gale K. Neurodevelopmental impact of antiepileptic drugs and seizures in the immature brain. Epilepsia 2007b;48(Suppl 5):19-26. (Pubitemid 47512198)
79. Koh S, Tibayan FD, Simpson JN, Jensen FE. NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia 2004;45:569-75. (Pubitemid 38802202)
80. Lau CG, Zukin RS. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007;8:413-26. (Pubitemid 46789232)
81. Laurie DJ, Bartke I, Schoepfer R, Naujoks K, Seeburg PH. Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Brain Res Mol Brain Res 1997;51:23-32. (Pubitemid 27504028)
82. Law AJ, Weickert CS, Webster MJ, Herman MM, Kleinman JE, Harrison PJ. Expression of NMDA receptor NR1, NR2A and NR2B subunit mRNAs during development of the human hippocampal formation. Eur J Neurosci 2003;18:1197-205. (Pubitemid 37115039)
83. Lechpammer M, Manning SM, Samonte F, Nelligan J, Sabo E, Talos DM, et al. Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia. Neuropathol Appl Neurobiol 2008;34:379-93.
84. LiuH,Kaur J,DashtipourK,Kinyamu R,RibakCE, Friedman LK. Suppression of hippocampal neurogenesis is associated with developmental stage, number of perinatal seizure episodes, and glucocorticosteroid level. Exp Neurol 2003;184:196-213. (Pubitemid 37444031)
85. Liu CL, Siesjo BK, Hu BR. Pathogenesis of hippocampal neuronal death after hypoxiaischemia changes during brain development. Neuroscience 2004;127:113-23. (Pubitemid 38829157)
86. LoTurco JJ, Owens DF, Heath MJ, Davis MB, Kriegstein AR. GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 1995;15:1287-98. (Pubitemid 26005367)
87. Luyt K, Varadi A, Molnar E. Functional metabotropic glutamate receptors are expressed in oligodendrocyte progenitor cells. J Neurochem 2003;84:1452-64. (Pubitemid 36343611)
88. Luyt K, Váradi A, Durant CF, Molnár E. Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis. J Neurochem 2006;99:641-56. (Pubitemid 44477218)
89. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA 2005;293:90-5. (Pubitemid 40066704)
90. Manning SM, Talos DM, Zhou C, Selip DB, Park HK, Park CJ, et al. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 2008;28:6670-8.
91. Maric D, Liu QY, Grant GM, Andreadis JD, Hu Q, Chang YH, et al. Functional ionotropic glutamate receptors emerge during terminal cell division and early neuronal differentiation of rat neuroepithelial cells. J Neurosci Res 2000;61:652-62.
92. Marsh ED, Brooks-Kayal AR, Porter BE. Seizures and antiepileptic drugs: does exposure alter normal brain development? Epilepsia 2006;47:1999-2010. (Pubitemid 44952250)
93. Maskell PD, Speder P, Newberry NR, Bermudez I. Inhibition of human α7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors. Br J Pharmacol 2003;140:1313-9. (Pubitemid 38117436)
94. McBain CJ, Mayer ML. N-methyl-D-aspartic acid receptor structure and function. Physiol Rev 1994;74:723-60.
95. McPherson RJ, Juul SE. Recent trends in erythropoietin-mediated neuroprotection. Int J Dev Neurosci 2008;26:103-11. (Pubitemid 351192267)
96. McPherson RJ, Juul SE. Erythropoietin for infants with hypoxic-ischemic encephalopathy. Curr Opin Pediatr 2010;22:139-45.
97. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 2009;360:1597-605.
98. Merrill JE, Benveniste EN. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 1996;19:331-8. (Pubitemid 26349062)
99. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994;12:529-40. (Pubitemid 24100885)
100. Nelson KB, Dambrosia JM, Iovannisci DM, Cheng S, Grether JK, Lammer E. Genetic polymorphisms and cerebral palsy in very preterm infants. Pediatr Res 2005;57:494-9. (Pubitemid 40389336)
101. Noda M, Nakanishi H, Nabekura J, Akaike N. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J Neurosci 2000;20:251-8. (Pubitemid 30220512)
102. O'Brien RJ, Kamboj S, Ehlers MD, Rosen KR, Fischbach GD, Huganir RL. Activitydependent modulation of synaptic AMPA receptor accumulation. Neuron 1998;21:1067-78. (Pubitemid 29018076)
103. Olney JW, Young C, Wozniak DF, Jevtovic-Todorovic V, Ikonomidou C. Do pediatric drugs cause developing neurons to commit suicide? Trends Pharmacol Sci 2004;25:135-9. (Pubitemid 38264503)
104. Ornoy A. Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy. Reprod Toxicol 2006;22:214-26. (Pubitemid 43994382)
105. Petralia RS, Wang YX, Wenthold RJ. The NMDA receptor subunits NR2A and NR2B show histological and ultrastructural localization patterns similar to those of NR1. J Neurosci 1994;14:6102-20. (Pubitemid 24307802)
106. Pickard L, Noel J, Henley JM, Collingridge GL, Molnar E. Developmental changes in synaptic AMPA and NMDA receptor distribution and AMPA receptor subunit composition in living hippocampal neurons. J Neurosci 2000;20:7922-31.
107. Pohl D, Bittigau P, Ishimaru MJ, Stadthaus D, Hubner C, Olney JW, et al. N-Methyl-Daspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci USA 1999;96:2508-13. (Pubitemid 29117946)
108. Rakhade SN, Jensen FE. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol 2009;5:380-91.
109. Ravishankar S, Ashraf QM, Fritz K, Mishra OP, Delivoria-Papadopoulos M. Expression of Bax and Bcl-2 proteins during hypoxia in cerebral cortical neuronal nuclei of newborn piglets: effect of administration of magnesium sulfate. Brain Res 2001;901:23-9. (Pubitemid 32718801)
110. Rezaie P. Microglia in the human nervous system during development. Neuroembryology 2003;2:18-31. (Pubitemid 37485334)
111. Ringler SL, Aye J, Byrne E, Anderson M, Turner CP. Effects of disrupting calcium homeostasis on neuronal maturation: early inhibition and later recovery. Cell Mol Neurobiol 2008;28:389-409.
112. Ritter LM, Unis AS, Meador-Woodruff JH. Ontogeny of ionotropic glutamate receptor expression in human fetal brain. Brain Res Dev Brain Res 2001;127:123-33. (Pubitemid 32378763)
113. Ritter LM, Vazquez DM, Meador-Woodruff JH. Ontogeny of ionotropic glutamate receptor subunit expression in the rat hippocampus. Brain Res Dev Brain Res 2002;139:227-36. (Pubitemid 35453909)
114. Roberts EB, Ramoa AS. Enhanced NR2A subunit expression and decreased NMDA receptor decay time at the onset of ocular dominance plasticity in the ferret. J Neurophysiol 1999;81:2587-91. (Pubitemid 29262585)
115. Roberts AC, Diez-Garcia J, Rodriguiz RM, Lopez IP, Lujan R, Martinez-Turrillas R, et al. Downregulation of NR3A-containing NMDARs is required for synapse maturation and memory consolidation. Neuron 2009;63:342-56.
116. Rosenberg PA, Dai W, Gan XD, Ali S, Fu J, Back SA, et al. Mature myelin basic proteinexpressing oligodendrocytes are insensitive to kainate toxicity. J Neurosci Res 2003;71:237-45. (Pubitemid 36055468)
117. Sanchez RM, Koh S, Rio C, Wang C, Lamperti ED, Sharma D, et al. Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures. J Neurosci 2001;21:8154-63. (Pubitemid 32952771)
118. Sanchez-Gomez MV, Alberdi E, Ibarretxe G, Torre I, Matute C. Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors. J Neurosci 2003;23:9519-28. (Pubitemid 37352052)
119. Sfaello I, Baud O, Arzimanoglou A, Gressens P. Topiramate prevents excitotoxic damage in the newborn rodent brain. Neurobiol Dis 2005;20:837-48. (Pubitemid 41619359)
120. Shouman B, Fontaine RH, Baud O, Schwendimann L, Keller M, Spedding M, et al. Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage. Br J Pharmacol 2006;148:442-51. (Pubitemid 43882080)
121. Stefovska VG, Uckermann O, Czuczwar M, Smitka M, Czuczwar P, Kis J, et al. Sedative and anticonvulsant drugs suppress postnatal neurogenesis. Ann Neurol 2008;64:434-45.
122. Suzuki M, Nelson AD, Eickstaedt JB, Wallace K, Wright LS, Svendsen CN. Glutamate enhances proliferation and neurogenesis in human neural progenitor cell cultures derived from the fetal cortex. Eur J Neurosci 2006;24:645-53. (Pubitemid 44232511)
123. Takai H, Katayama K, Uetsuka K, Nakayama H, Doi K. Distribution of N-methyl-Daspartate receptors (NMDARs) in the developing rat brain. Exp Mol Pathol 2003;75:89-94. (Pubitemid 36794383)
124. Talos DM, Fishman RE, Park H, Folkerth RD, Follett PL, Volpe JJ, et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex. J Comp Neurol 2006a;497:42-60. (Pubitemid 43844567)
125. Talos DM, Follett PL, Folkerth RD, Fishman RE, Trachtenberg FL, Volpe JJ, et al. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole- propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex. J Comp Neurol 2006b;497:61-77. (Pubitemid 43844568)
126. Traa BS, Mulholland JD, Kadam SD, Johnston MV, Comi AM. Gabapentin neuroprotection andseizure suppression inimmaturemouse brainischemia. Pediatr Res 2008;64:81-5.
127. Tsuji M, Wilson MA, Lange MS, Johnston MV. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol 2004;189:58-65. (Pubitemid 39024455)
128. Vallano ML. Developmental aspects of NMDA receptor function. Crit Rev Neurobiol 1998;12:177-204. (Pubitemid 29002438)
129. van den Pol AN, Obrietan K, Belousov AB, Yang Y, Heller HC. Early synaptogenesis in vitro: role of axon target distance. J Comp Neurol 1998;399:541-60. (Pubitemid 28411115)
130. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009;8:110-24.
131. Watanabe M, Inoue Y, Sakimura K, Mishina M. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 1992;3:1138-40. (Pubitemid 23034721)
132. Wilder RT, Flinck RP, Sprung J, Katusic SK, Barbaresi WJ, Mickelson C, Gleich SJ, Schroeder DR, Weaver AL, Warner DO. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology 2009;110:796-804.
133. Woodward LJ, Anderson PJ, Austin NC, Howard K, Inder TE. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med 2006;355:685-94.
134. Xu H, Barks JD, Liu YQ, Silverstein FS. AMPA-Induced suppression of oligodendroglial gene expression in neonatal rat brain. Brain Res Dev Brain Res 2001;132:175-8. (Pubitemid 34024959)
135. Xu G, Ong J, Liu YQ, Silverstein FS, Barks JD. Subventricular zone proliferation after alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated neonatal brain injury. Dev Neurosci 2005;27:228-34. (Pubitemid 41096230)
136. Yager JY, Ashwal S. Animal models of perinatal hypoxic-ischemic brain damage. Pediatr Neurol 2009;40:156-67.
137. Yang Z, Levison SW. Perinatal hypoxic/ischemic brain injury induces persistent production of striatal neurons from subventricular zone progenitors. Dev Neurosci 2007;29:331-40. (Pubitemid 47343687)
138. Yerby MS, Leavitt A, Erickson DM, McCormick KB, Loewenson RB, Sells CJ, et al. Antiepileptics and the development of congenital anomalies. Neurology 1992;42:132-40.
139. Yoshioka A, Yamaya Y, Saiki S, Kanemoto M, Hirose G, Beesley J, et al. Non-N-methyl-Daspartate glutamate receptors mediate oxygen-glucose deprivation-induced oligodendroglial injury. Brain Res 2000;854:207-15. (Pubitemid 30067677)
140. Yuan J, Lipinski M, Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron 2003;40:401-13. (Pubitemid 37244104)
141. Zhang G, Raol YS, Hsu FC, Brooks-Kayal AR. Long-term alterations in glutamate receptor and transporter expression following early-life seizures are associated with increased seizure susceptibility. J Neurochem 2004;88:91-101. (Pubitemid 38030212)
142. Zhu JJ, Esteban JA, Hayashi Y, Malinow R. Postnatal synaptic potentiation: delivery of GluR4-containing AMPA receptors by spontaneous activity. Nat Neurosci 2000;3:1098-106.